Jefferies Group’s Edwards Lifesciences EW Stock Holding History

Jefferies Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-106,400	Closed	-$13.8M	–	1638
2021 Q4	$13.8M	Buy	+106,400	New	+$12.4M	0.08%	210
2020 Q2	–	Sell	-14,400	Closed	-$941K	–	1541
2020 Q1	$941K	Buy	+14,400	New	+$1.04M	0.01%	1042
2019 Q4	–	Sell	-33,600	Closed	-$2.46M	–	2667
2019 Q3	$2.46M	Buy	+33,600	New	+$2.36M	0.02%	949
2019 Q2	–	Sell	-498,600	Closed	-$31.8M	–	2623
2019 Q1	$31.8M	Buy	+498,600	New	+$28.5M	0.26%	42
2018 Q4	–	Sell	-16,800	Closed	-$975K	–	2258
2018 Q3	$975K	Sell	16,800 -86,700	-84%	-$4.24M	0.01%	1342
2018 Q2	$5.02M	Buy	+103,500	New	+$4.83M	0.03%	501
2016 Q3	–	Sell	-1,500	Closed	-$50K	–	2289
2016 Q2	$50K	Sell	1,500 -238,800	-99%	-$8.17M	﹤0.01%	1992
2016 Q1	$7.07M	Buy	+240,300	New	+$6.63M	0.04%	362

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's EW Position: Q3 2022 in Review

Jefferies Group opened a new position in Edwards Lifesciences (EW) in Q3 2022: 10,030 shares worth $829K. The stake represents 0.01% of the portfolio and ranks #862 among its holdings. This is a return to the name: Jefferies Group previously reported a position in EW as recently as Q4 2021.

Jefferies Group first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $10.2M in Q3 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Jefferies Group held 10,030 shares of Edwards Lifesciences worth $829K as of Q3 2022.
Edwards Lifesciences was a new Jefferies Group position in Q3 2022.
Edwards Lifesciences made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #862 holding.
Jefferies Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
Jefferies Group's Edwards Lifesciences position peaked at $10.2M in Q3 2021.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.